Cases & Deals

  • Home
  • Practices
  • Alizé Pharma SAS acquired by Millendo Therapeutics, Inc.

Share

Alizé Pharma SAS acquired by Millendo Therapeutics, Inc.

December 2017

Client(s) Alizé Pharma SAS

Jones Day advised Alizé Pharma SAS, a French clinical-stage biotech private company, in connection with its sale in a stock-for-stock transaction to Millendo Therapeutics, Inc., a U.S. clinical-stage biotech private company focused on developing novel treatments for endocrine diseases.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.